Work

Efficacy and Safety of Dupilumab in Patients With Persistent Asthma From the Asia-Pacific Region: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study

Year: 2023

Type: conference-abstract

DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4767

Authors: Q. Zhang, Z. Nanshan, S. Dhooria, X. Fu, J. Lin, W. Li, E. Laws, L. Mannent, Y. Wang, V. Li, A. Li, C.-C. Hu, D.J. Lederer, R.M. Abdulai, L. Robinson

Institutions: First Affiliated Hospital of Guangzhou Medical University, Post Graduate Institute of Medical Education and Research, Inner Mongolia Medical University, Wenzhou Medical University, Second Affiliated Hospital of Zhejiang University, Sanofi (United States), Sanofi (France), Regeneron (United States)

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367604479

Cites:

Cited by:

Related to: 10